Abstract
In search of a molecular site and mechanism of action for anaesthetics, we have examined the effects of racemic ketamine on single human CNS sodium channels with the new planar lipid bilayer technique. In the dose range studied (0.05-9.2 mmol litre-1) ketamine depressed in a dose-dependent manner two major functions of the sodium channel, by reducing the fractional open time in a voltage-independent manner (ED50 1.1 mmol litre-1; maximal conductance block 71%) and by interfering with the voltage-dependent, steady-state activation. These actions occurred at concentrations which were greater than those used clinically in general anaesthesia (up to 0.02 mmol litre-1), therefore they reflect local rather than general anaesthetic effects which may be related to the hydrophobic properties of ketamine. In comparison with two other i.v. anaesthetic agents, pentobarbitone and propofol, racemic ketamine behaves differently at both the molecular and the clinical level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
